https://www.marketscreener.com/quote/stock/MACROGENICS-INC-14484280/news/MacroGenics-Prophylactic-Ruxolitinib-for-CRS-in-RR-AML-Pts-Treated-w-Flotetuzumab-Uy-31954109/?utm_source=telegram&utm_medium=social&utm_campaign=share